Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature

被引:15
作者
Morgensztern, D
Rosado, MF
Silva, O
Santos, ES
Abdullah, SA
Goodman, M
Hamilton-Nelson, K
Rosenblatt, JD
Lossos, IS
机构
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Hematol & Oncol, Div Biostat,Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Sch Med, Dept Med, Div Hematol Oncol, Miami, FL USA
[3] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA
关键词
hepatitis C; non-Hodgkin's lymphoma;
D O I
10.1080/10428190400007771
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The etiology of non-Hodgkin's lymphoma is unknown in the majority of the cases. Although Epstein-Barr virus, human T-cell leukemia-lymphoma virus and human herpes virus-8 have been established as casual agents in the pathogenesis of specific types of lymphoma, the role of hepatitis C virus (HCV) in lymphomagenesis remains controversial, with marked geographic variability. We conducted an epidemiologic study to evaluate the prevalence of hepatitis C virus infection in patients with lymphoma in South Florida. Ninety consecutive patients with lymphoma and 96 consecutive control patients with solid tumors were tested for HCV. HCV infection was detected in 2 patients with NHL (2.2%) and in 4 control patients (4.1%). Our study does not support the association between HCV and lymphoma in South Florida, US.
引用
收藏
页码:2459 / 2464
页数:6
相关论文
共 50 条
[1]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[2]   Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles [J].
Arcaini, L ;
Paulli, M ;
Boveri, E ;
Vallisa, D ;
Bernuzzi, P ;
Orlandi, E ;
Incardona, P ;
Brusamolino, E ;
Passamonti, F ;
Burcheri, S ;
Schena, C ;
Pascutto, C ;
Cavanna, L ;
Margrini, U ;
Lazzarino, M .
CANCER, 2004, 100 (01) :107-115
[3]   No association between lymphoma and hepatitis C virus [J].
Avilés, A ;
Valdez, L ;
Halabe, J ;
Neri, N ;
Nellen, H ;
Huerta-Guzmán, J ;
Nambo, MJ .
MEDICAL ONCOLOGY, 2003, 20 (02) :165-168
[4]   Non-Hodgkin's lymphoma and hepatitis C virus infection [J].
Brind, AM ;
Watson, JP ;
Burt, A ;
Kestevan, P ;
Wallis, J ;
Proctor, SJ ;
Bassendine, MF .
LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) :127-130
[5]  
Cesarman Ethel, 1999, Current Opinion in Oncology, V11, P322, DOI 10.1097/00001622-199909000-00002
[6]  
Chindamo MC, 2002, ONCOL REP, V9, P657
[7]   No association between hepatitis C and B-cell lymphoma [J].
Collier, JD ;
Zanke, B ;
Moore, M ;
Kessler, G ;
Krajden, M ;
Shepherd, F ;
Heathcote, J .
HEPATOLOGY, 1999, 29 (04) :1259-1261
[8]   Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients [J].
Cucuianu, A ;
Patiu, M ;
Duma, M ;
Basarab, C ;
Soritau, O ;
Bojan, A ;
Vasilache, A ;
Mates, M ;
Petrov, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) :353-356
[9]  
DeRosa G, 1997, AM J HEMATOL, V55, P77, DOI 10.1002/(SICI)1096-8652(199706)55:2<77::AID-AJH5>3.0.CO
[10]  
2-#